Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
It has been known for decades that the tumor extracellular matrix (ECM) is dysfunctional leading to loss of tissue architecture and promotion of tumor growth. The altered ECM and tumor fibrogenesis leads to tissue stiffness that act as a physical barrier to immune cell infiltration into the tumor mi...
Main Authors: | Dallas B. Flies, Solomon Langermann, Christina Jensen, Morten A. Karsdal, Nicholas Willumsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1199513/full |
Similar Items
-
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1
by: Saskia V. Vijver, et al.
Published: (2021-10-01) -
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
by: M Ines Pascoal Ramos, et al.
Published: (2021-06-01) -
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
by: Neel I. Nissen, et al.
Published: (2019-03-01) -
Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors
by: Jeppe Thorlacius-Ussing, et al.
Published: (2022-04-01) -
Navigating the Collagen Jungle: The Biomedical Potential of Fiber Organization in Cancer
by: Jonathan N. Ouellette, et al.
Published: (2021-01-01)